My research program has three major areas of focus: (1) oncolytic virotherapy, (2) investigating novel immune checkpoint ligands and receptors, and (3) developing/advancing single vector CRISPR/HDR technology.

Principal Investigator

Matthew VanBrocklin, PhD
Principal Investigator
matthew.vanbrocklin@hci.utah.edu

Cancer Center Bio

NEW FRONTIERS IN MELANOMA RESEARCH

Read more about the VanBrocklin Lab research in the 2013 Top Science Report.